Influenza vaccines uptake may increase in the coming years if HCWs are educated and thus convinced (that is not the case so far) of the benefit of promoting influenza vaccines more adapted to the elderly (high dose, or adjuvanted); we know better now that ageing weakens the efficacy of the classic vaccine - for many HCWs, thus the benefit achieved is not worth (the smallest) risks to promote all vaccines useful at this age to organize easy point of care access